Jazz Pharmaceuticals is a global biopharmaceutical company with a Canadian presence in Mississauga focused on serious diseases with high unmet need. The company emphasizes rare disease, sleep medicine, epilepsy and oncology, and describes a pipeline and commercial portfolio built around difficult-to-treat and complex conditions.